SCHEMBL10132285

SCHEMBL10132285

CC(C)(C)OC(=O)N1CCC[C@H]1C(O)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
NPC1 O15118 2/20 0.42
STS P08842 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 2/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
TSHR P16473 2/20 0.42
F2R P25116 1/20 0.42
CNR1 P21554 2/20 0.42
ATM Q13315 1/20 0.42
CCR1 P32246 1/20 0.40
UCHL1 P09936 1/20 0.40
USP30 Q70CQ3 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132323 0.89 NPSR1 (0.49) ALDH1A1MEN1KMT2ANPC1MAPT
SCHEMBL25971634 0.89 NPSR1 (0.49) ALDH1A1MEN1KMT2ANPC1MAPT
SCHEMBL3129810 0.88 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ANPC1STS
SCHEMBL925281 0.88 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ANPC1STS
SCHEMBL3129802 0.88 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ANPC1STS
SCHEMBL925279 0.88 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ANPC1STS
SCHEMBL925410 0.88 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ANPC1STS
SCHEMBL10132244 0.88 MEN1 (0.43) ALDH1A1MEN1KMT2ANPC1MAPT
SCHEMBL6990025 0.88 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ANPC1STS
SCHEMBL29997863 0.88 KLK7 (0.45) ALDH1A1MEN1KMT2ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374794-B1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO CO LTD (JP) 2015-11-04 EP disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
EP-2374794-A1 CYCLIC AMINE COMPOUNDS Daiichi Sankyo Company, Limited (JP) 2011-10-12 EP disclosed
WO-2010074088-A1 CYCLIC AMINE COMPOUNDS 第一三共株式会社 (JP) 2010-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319468-A1 CYCLIC AMINE COMPOUNDS RYR2, CASR, RYR1 ALDH1A1 2584/4885MEN1 1659/4885KMT2A 2928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.